MX2009007006A - Pirimidinas 5,6-sustituidas inhibidoras del virus de inmunodeficiencia humana. - Google Patents
Pirimidinas 5,6-sustituidas inhibidoras del virus de inmunodeficiencia humana.Info
- Publication number
- MX2009007006A MX2009007006A MX2009007006A MX2009007006A MX2009007006A MX 2009007006 A MX2009007006 A MX 2009007006A MX 2009007006 A MX2009007006 A MX 2009007006A MX 2009007006 A MX2009007006 A MX 2009007006A MX 2009007006 A MX2009007006 A MX 2009007006A
- Authority
- MX
- Mexico
- Prior art keywords
- 6alkyl
- 6alkyloxy
- cyano
- polyhaloc1
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Abstract
Se describen inhibidores de la duplicación del VIH de la fórmula: (ver fórmula (I)) R1 es hidrógeno; arilo; formilo; alquil(C1-6)carbonilo, alquilo de C1-6; alquil(C1-6)oxicarbonilo; R2 R3, R7 y R8 son hidrógeno; hidroxi; halógeno; cicloalquilo de C3-7; alquiloxi de C1-6; carboxilo; alquil(C1-6)oxicarbonilo; ciano; nitro; amino; mono- o di-alquil(C1-6)amino; polihalo-alquilo de C1-6; polihalo-alquiloxi de C1-6;-C(=O)R10; alquilo de C1-6 sustituido opcionalmente con halógeno, ciano o -C(=O)R10; alquilo de C1-6 sustituido opcionalmente, alquenilo de C2-6, o alquinilo de C2-6; R4 y R9 son hidroxi; halógeno; cilcoalquilo de C3-7; alquiloxi de C1-6; carboxilo; alquil(1-6)oxicarbonilo; formilo; ciano; nitro; amino; mono- o di-alquil(C1-6)amino; polihalo-alquilo de C1-6; polihalo-alquiloxi de C1-6; -C(=O)R10, ciano; -S(=O)rR10; -NH-S(=O)2R10; -NHC(=O)H; -C(=O)NHNH2; -NHC(=O)R10; -Het; -Y-Het; alquilo de C1-6 sustituido opcionalmente, alquenilo de C2-6 o alquinilo de C2-6; R5 es alquenilo de C2-6; o alquinilo de C2-6, ambos sustituidos con ciano; aminocarbonilo, mono- y di-alquil(C1-6)aminocarbonilo, arilo, piridilo, tienilo, furanilo, o con uno o dos grupos alquiloxi de C1-6; Het; -C(=O)NR5aR5b; -CH(OR5c)R5d; X es -NR1-, -O-, -CH2-, o -S-; composiciones farmacéuticas que contienen estos compuestos como ingredientes activos, y procedimientos de preparación de dichos compuestos y composiciones.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06127328 | 2006-12-29 | ||
PCT/EP2007/064606 WO2008080965A2 (en) | 2006-12-29 | 2007-12-28 | Hiv inhibiting 5,6-substituted pyrimidines |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009007006A true MX2009007006A (es) | 2009-07-09 |
Family
ID=39310923
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009007006A MX2009007006A (es) | 2006-12-29 | 2007-12-28 | Pirimidinas 5,6-sustituidas inhibidoras del virus de inmunodeficiencia humana. |
Country Status (12)
Country | Link |
---|---|
US (1) | US8318736B2 (es) |
EP (2) | EP2114902B1 (es) |
JP (1) | JP5283633B2 (es) |
KR (1) | KR20090094084A (es) |
CN (2) | CN106045965A (es) |
AU (1) | AU2007341228B2 (es) |
BR (1) | BRPI0722079B8 (es) |
CA (2) | CA2674185C (es) |
EA (1) | EA020749B1 (es) |
ES (2) | ES2523863T3 (es) |
MX (1) | MX2009007006A (es) |
WO (1) | WO2008080965A2 (es) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101031558B (zh) | 2004-09-30 | 2011-10-05 | 泰博特克药品有限公司 | 抑制人类免疫缺陷病毒的5-杂环基嘧啶 |
AU2005288866B2 (en) | 2004-09-30 | 2012-07-26 | Janssen Sciences Ireland Uc | HIV inhibiting 5-substituted pyrimidines |
BRPI0619708A2 (pt) * | 2005-11-03 | 2011-10-11 | Vertex Pharma | composto, composição, método para inibir a atividade da proteìna aurora quinase numa amostra biológica, método para tratar distúrbio proliferativo e método para tratar cáncer |
MX2008012576A (es) * | 2006-03-30 | 2008-10-10 | Tibotec Pharm Ltd | Pirimidinas 5-amido sustituidas inhibidoras del virus de inmunodeficiencia humana. |
DK2114901T3 (da) | 2006-12-29 | 2014-06-30 | Janssen R & D Ireland | Hiv-inhiberende 6-substituerede pyrimidiner |
US8138339B2 (en) | 2008-04-16 | 2012-03-20 | Portola Pharmaceuticals, Inc. | Inhibitors of protein kinases |
US8063058B2 (en) | 2008-04-16 | 2011-11-22 | Portola Pharmaceuticals, Inc. | Inhibitors of syk and JAK protein kinases |
EP3210609A1 (en) | 2008-05-21 | 2017-08-30 | Ariad Pharmaceuticals, Inc. | Phosphorous derivatives as kinase inhibitors |
US9273077B2 (en) | 2008-05-21 | 2016-03-01 | Ariad Pharmaceuticals, Inc. | Phosphorus derivatives as kinase inhibitors |
CA2986640C (en) | 2008-06-27 | 2019-03-26 | Celgene Avilomics Research, Inc. | Heteroaryl compounds and uses thereof |
US8338439B2 (en) | 2008-06-27 | 2012-12-25 | Celgene Avilomics Research, Inc. | 2,4-disubstituted pyrimidines useful as kinase inhibitors |
US11351168B1 (en) | 2008-06-27 | 2022-06-07 | Celgene Car Llc | 2,4-disubstituted pyrimidines useful as kinase inhibitors |
JP5599791B2 (ja) | 2008-07-29 | 2014-10-01 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 5−アルキニル−ピリミジン |
TW201020245A (en) * | 2008-08-20 | 2010-06-01 | Schering Corp | Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
CA2734489C (en) * | 2008-08-20 | 2016-11-08 | Southern Research Institute | Ethenyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
CA2760794C (en) | 2009-05-05 | 2017-07-25 | Dana Farber Cancer Institute | Egfr inhibitors and methods of treating disorders |
US8618111B2 (en) | 2010-01-26 | 2013-12-31 | Boehringer Ingelheim International Gmbh | 5-alkynyl-pyrimidines |
UY33199A (es) | 2010-01-26 | 2011-08-31 | Boehringer Ingelheim Int | 5-alquinil-pirimidinas. |
KR20130099040A (ko) | 2010-08-10 | 2013-09-05 | 셀진 아빌로믹스 리서치, 인코포레이티드 | Btk 억제제의 베실레이트 염 |
EP2635285B1 (en) | 2010-11-01 | 2017-05-03 | Celgene Avilomics Research, Inc. | Heteroaryl compounds and uses thereof |
US8975249B2 (en) | 2010-11-01 | 2015-03-10 | Celgene Avilomics Research, Inc. | Heterocyclic compounds and uses thereof |
US8796255B2 (en) | 2010-11-10 | 2014-08-05 | Celgene Avilomics Research, Inc | Mutant-selective EGFR inhibitors and uses thereof |
US9126949B2 (en) | 2011-04-25 | 2015-09-08 | Hetero Research Foundation | Process for rilpivirine |
BR112013027734A2 (pt) | 2011-05-04 | 2017-08-08 | Ariad Pharma Inc | compostos para a inibição de proliferação celular em cânceres impulsionados pelo egfr, método e composição farmacêutica |
CA2853498A1 (en) | 2011-10-28 | 2013-05-02 | Celgene Avilomics Research, Inc. | Methods of treating a bruton's tyrosine kinase disease or disorder |
KR102019530B1 (ko) | 2011-11-23 | 2019-09-06 | 포톨라 파마슈티컬스, 인코포레이티드 | 피라진 키나아제 저해제 |
RS57901B1 (sr) | 2012-03-15 | 2019-01-31 | Celgene Car Llc | Soli inhibitora kinaze receptora epidermalnog faktora rasta |
EP2825041B1 (en) | 2012-03-15 | 2021-04-21 | Celgene CAR LLC | Solid forms of an epidermal growth factor receptor kinase inhibitor |
JP6469567B2 (ja) | 2012-05-05 | 2019-02-13 | アリアド・ファーマシューティカルズ・インコーポレイテッド | Egfr発動性がんの細胞増殖阻害用化合物 |
EP2935226A4 (en) | 2012-12-21 | 2016-11-02 | Celgene Avilomics Res Inc | HETEROARYL COMPOUNDS AND USES THEREOF |
PE20151274A1 (es) | 2013-02-08 | 2015-09-12 | Celgene Avilomics Res Inc | Inhibidores de erk y sus usos |
US9611283B1 (en) | 2013-04-10 | 2017-04-04 | Ariad Pharmaceuticals, Inc. | Methods for inhibiting cell proliferation in ALK-driven cancers |
US9492471B2 (en) | 2013-08-27 | 2016-11-15 | Celgene Avilomics Research, Inc. | Methods of treating a disease or disorder associated with Bruton'S Tyrosine Kinase |
CN103483272B (zh) * | 2013-09-29 | 2015-10-21 | 山东大学 | 间二芳烃-多取代嘧啶类衍生物及其制备方法与应用 |
US9415049B2 (en) | 2013-12-20 | 2016-08-16 | Celgene Avilomics Research, Inc. | Heteroaryl compounds and uses thereof |
ES2741785T3 (es) | 2014-08-13 | 2020-02-12 | Celgene Car Llc | Formas y composiciones de un inhibidor de ERK |
CN106967047A (zh) * | 2017-03-29 | 2017-07-21 | 山东大学 | 一种取代二芳基烟酰胺类衍生物及其制备方法与应用 |
JP6545746B2 (ja) * | 2017-05-09 | 2019-07-17 | 山田化学工業株式会社 | 色素化合物 |
DE102017004596B4 (de) * | 2017-05-13 | 2021-02-11 | Alzchem Trostberg Gmbh | Verfahren zur Herstellung von Phenylguanidinen oder deren Salze |
CN111285859B (zh) * | 2020-04-02 | 2021-07-02 | 山东大学 | 一类以hiv-1逆转录酶为靶点的2,4,5-三取代嘧啶类化合物及其制备方法与应用 |
CN111560013B (zh) * | 2020-06-08 | 2023-04-07 | 中山大学 | 一种自噬抑制剂及其应用 |
CN111875548A (zh) * | 2020-07-16 | 2020-11-03 | 山东大学 | 一种5位芳环取代的二芳基嘧啶类衍生物及其制备方法与应用 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3459731A (en) | 1966-12-16 | 1969-08-05 | Corn Products Co | Cyclodextrin polyethers and their production |
HUP9900730A3 (en) | 1995-11-23 | 2001-04-28 | Janssen Pharmaceutica Nv | Solid mixtures of cyclodextrins prepared via melt-extrusion |
NO311614B1 (no) | 1996-10-01 | 2001-12-17 | Janssen Pharmaceutica Nv | Substituerte diamino-1,3,5-triazinderivater |
DE69905306T2 (de) | 1998-03-27 | 2003-11-27 | Janssen Pharmaceutica Nv | HIV hemmende Pyrimidin Derivate |
EP0945447A1 (en) | 1998-03-27 | 1999-09-29 | Janssen Pharmaceutica N.V. | Trisubstituted 1,3,5-triazine derivatives for treatment of HIV infections |
NZ511116A (en) | 1998-11-10 | 2003-08-29 | Janssen Pharmaceutica Nv | HIV replication inhibiting pyrimidines |
GB9828511D0 (en) | 1998-12-24 | 1999-02-17 | Zeneca Ltd | Chemical compounds |
WO2001085700A2 (en) | 2000-05-08 | 2001-11-15 | Janssen Pharmaceutica N.V. | Hiv replication inhibiting pyrimidines and triazines |
NZ526469A (en) | 2000-12-21 | 2005-10-28 | Vertex Pharma | Pyrazole compounds useful as protein kinase inhibitors |
JO3429B1 (ar) | 2001-08-13 | 2019-10-20 | Janssen Pharmaceutica Nv | مشتقات برميدينات مثبطة فيروس الايدز |
TWI329105B (en) | 2002-02-01 | 2010-08-21 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds and their uses |
AR039540A1 (es) * | 2002-05-13 | 2005-02-23 | Tibotec Pharm Ltd | Compuestos microbicidas con contenido de pirimidina o triazina |
JP2006508145A (ja) | 2002-11-15 | 2006-03-09 | テイボテク・フアーマシユーチカルズ・リミテツド | 抗感染化合物としての置換インドールピリジニウム |
CL2004000303A1 (es) * | 2003-02-20 | 2005-04-08 | Tibotec Pharm Ltd | Compuestos derivados de pirimidinas y triazinas; proceso de preparacion; composicion farmaceutica; y su uso para inhibir la replicacion del vih. |
US7504396B2 (en) | 2003-06-24 | 2009-03-17 | Amgen Inc. | Substituted heterocyclic compounds and methods of use |
MX2007003798A (es) * | 2004-09-30 | 2007-04-23 | Tibotec Pharm Ltd | Pirimidinas 5-sustituidas con carbociclos o heterociclos inhibidoras del vih. |
AU2005288866B2 (en) | 2004-09-30 | 2012-07-26 | Janssen Sciences Ireland Uc | HIV inhibiting 5-substituted pyrimidines |
CN101031558B (zh) | 2004-09-30 | 2011-10-05 | 泰博特克药品有限公司 | 抑制人类免疫缺陷病毒的5-杂环基嘧啶 |
WO2006079656A1 (en) * | 2005-01-27 | 2006-08-03 | Tibotec Pharmaceuticals Ltd. | Hiv inhibiting 2-( 4-cyanophenylamino) pyrimidine derivatives |
MX2008012576A (es) | 2006-03-30 | 2008-10-10 | Tibotec Pharm Ltd | Pirimidinas 5-amido sustituidas inhibidoras del virus de inmunodeficiencia humana. |
DK2114901T3 (da) | 2006-12-29 | 2014-06-30 | Janssen R & D Ireland | Hiv-inhiberende 6-substituerede pyrimidiner |
-
2007
- 2007-12-28 JP JP2009543477A patent/JP5283633B2/ja active Active
- 2007-12-28 EP EP07858202.0A patent/EP2114902B1/en active Active
- 2007-12-28 ES ES07858202.0T patent/ES2523863T3/es active Active
- 2007-12-28 KR KR1020097011042A patent/KR20090094084A/ko not_active Application Discontinuation
- 2007-12-28 CN CN201610109305.5A patent/CN106045965A/zh active Pending
- 2007-12-28 EA EA200970656A patent/EA020749B1/ru not_active IP Right Cessation
- 2007-12-28 AU AU2007341228A patent/AU2007341228B2/en active Active
- 2007-12-28 EP EP14170114.4A patent/EP2781510B1/en active Active
- 2007-12-28 MX MX2009007006A patent/MX2009007006A/es active IP Right Grant
- 2007-12-28 US US12/521,379 patent/US8318736B2/en active Active
- 2007-12-28 BR BRPI0722079A patent/BRPI0722079B8/pt active IP Right Grant
- 2007-12-28 CA CA2674185A patent/CA2674185C/en active Active
- 2007-12-28 WO PCT/EP2007/064606 patent/WO2008080965A2/en active Application Filing
- 2007-12-28 CA CA2923637A patent/CA2923637C/en active Active
- 2007-12-28 CN CNA2007800486111A patent/CN101573342A/zh active Pending
- 2007-12-28 ES ES14170114.4T patent/ES2618057T3/es active Active
Also Published As
Publication number | Publication date |
---|---|
WO2008080965A2 (en) | 2008-07-10 |
ES2523863T3 (es) | 2014-12-02 |
US8318736B2 (en) | 2012-11-27 |
BRPI0722079A2 (pt) | 2014-04-08 |
AU2007341228B2 (en) | 2013-04-18 |
EA200970656A1 (ru) | 2009-12-30 |
BRPI0722079B8 (pt) | 2021-05-25 |
CA2674185C (en) | 2017-02-28 |
AU2007341228A1 (en) | 2008-07-10 |
EP2114902B1 (en) | 2014-09-17 |
KR20090094084A (ko) | 2009-09-03 |
WO2008080965A3 (en) | 2008-09-04 |
EP2114902A2 (en) | 2009-11-11 |
CN106045965A (zh) | 2016-10-26 |
EA020749B1 (ru) | 2015-01-30 |
US20100261722A1 (en) | 2010-10-14 |
CA2923637A1 (en) | 2008-07-10 |
BRPI0722079B1 (pt) | 2020-01-14 |
ES2618057T3 (es) | 2017-06-20 |
CA2674185A1 (en) | 2008-07-10 |
CN101573342A (zh) | 2009-11-04 |
JP2010514736A (ja) | 2010-05-06 |
JP5283633B2 (ja) | 2013-09-04 |
EP2781510A1 (en) | 2014-09-24 |
EP2781510B1 (en) | 2016-12-14 |
CA2923637C (en) | 2018-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009007006A (es) | Pirimidinas 5,6-sustituidas inhibidoras del virus de inmunodeficiencia humana. | |
MX2009007005A (es) | Pirimidinas 6-sustituidas que inhiben el virus de inmunodeficiencia humana. | |
HRP20100696T1 (hr) | Hiv inhibirajuci 5-(hidroksimetilen i aminometilen) supstituirani pirimidini | |
MX2007003319A (es) | Derivados heterociclicos y su uso como agentes terapeuticos. | |
HK1115326A1 (en) | Methods and compositions for the treatment of persistent hiv infections by inhibiting the programmed cell death 1 (pd-1) pathway | |
WO2006034446A3 (en) | Pyridine derivatives for inhibiting human stearoyl-coa-desaturase | |
NL1026761A1 (nl) | 3,5-gedisubstitueerde indazoolverbindingen, farmaceutische preparaten en werkwijzen voor het medieren of remmen van celproliferatie. | |
PE20090714A1 (es) | Imidazopiridazinas y pirrolo-pirimidinas sustituidas como inhibidores de cinasa de lipido | |
GEP20115161B (en) | Heterocyclic amide derivatives useful as microbiocides | |
WO2007084595A3 (en) | Carbocyclic and heterocyclic arylsulfones as gamma secretase inhibitors | |
WO2009054332A1 (ja) | ピリドン置換ジヒドロピラゾロピリミジノン誘導体 | |
JO3181B1 (ar) | مشتقات كمحول ثاني الكيل البايردينيل - أحادي الفينيل كأنزيم ثنائي استرات الفوسفود | |
TW200712060A (en) | Thiophene compound having phosphoric ester and process for producing the same | |
TW200833694A (en) | Substituted piperidines containing a heteroarylamide or heteroarylphenyl moiety | |
AR079550A1 (es) | Derivados de pirazol | |
HRP20120762T1 (hr) | Tetrasupstituirani piridazini kao inhibitori hedgehog puta | |
MX2010000658A (es) | Derivados de pirimidina 934. | |
IL200469A0 (en) | Benzimidazole derivatives | |
AR054587A1 (es) | Derivados de quinolina antibacterianos | |
MX2010006882A (es) | Derivado novedoso de catecol, composición farmaceutica que contiene el mismo, uso del derivado de catecol, y uso de la composición farmaceutica. | |
IL207639A (en) | PyrrollopyrimidineCarboxylate compounds, preparations containing them and their uses | |
MX2009004140A (es) | Compuestos heterociclicos y su uso como inhibidores de la glucogeno sintasa quinasa 3. | |
MX2011011112A (es) | Compuestos antivirales heterociclicos. | |
AR064153A1 (es) | Derivados de quinolina antibacterianos. procesos de obtencion y composiciones farmaceuticas. | |
MX2011012541A (es) | Compuestos heterociclicos antivirales. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |